IllumiNeuro Peptide Blend Dosage Calculator, Benefits & Side Effects

Subcutaneous injection is the most commonly described administration route in research and vendor materials, though some users report intranasal use for more direct central nervous system exposure. Combined subcutaneous use of this specific four-peptide mixture is less documented than intranasal use of the individual peptides, so the comparative pharmacokinetics of the blend are not well characterized.

Detailed adverse-event data specific to the combined four-peptide blend is not available in the literature. Because each component is described as neuroactive (affecting mood, alertness, or cognition), sources caution against combining the blend with other stimulants or cognitive enhancers without careful monitoring, given the potential for additive or unpredictable effects. As an unregulated research blend, it has not undergone the safety testing required to characterize its side-effect profile in humans.

As with most peptides, lyophilized (freeze-dried) vials should be kept refrigerated at about 2-8°C (36-46°F), protected from light, and not frozen. Once reconstituted with bacteriostatic water, the solution is generally described as stable under refrigeration for about 28 days, though stability can vary by formulation and manufacturer.

Illumineuro is sold by research chemical suppliers labeled 'for research purposes only' and is not an FDA-approved medication or dietary supplement. It is not approved for human consumption, diagnosis, treatment, or prevention of any disease. Two of its components (Semax and Selank) are approved pharmaceuticals in Russia but not in the United States or most other countries, and buyers should understand that purchasing this product does not carry any regulatory endorsement for personal use.